Targets for Antibiotic and Healthcare Resource Stewardship in Inpatient Community-acquired Pneumonia: a Comparison of Management Practices with National Guideline Recommendations

Overview

Journal Infection

Date 2012 Nov 20

PMID 23160837

Citations 11

Authors

T C Jenkins

S A Stella

L Cervantes

B C Knepper

A L Sabel

C S Price

L Shockley

M E Hanley

P S Mehler

W J Burman

Affiliations

Soon will be listed here.

Abstract

Purpose: Community-acquired pneumonia (CAP) is the most common infection leading to hospitalization in the USA. The objective of this study was to evaluate management practices for inpatient CAP in relation to Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines to identify opportunities for antibiotic and health care resource stewardship.

Methods: This was a retrospective cohort study of adults hospitalized for CAP at a single institution from 15 April 2008 to 31 May 2009.

Results: Of the 209 patients with CAP who presented to Denver Health Medical Center during the study period and were hospitalized, 166 (79 %) and 43 (21 %) were admitted to a medical ward and the intensive care unit (ICU), respectively. Sixty-one (29 %) patients were candidates for outpatient therapy per IDSA/ATS guidance with a CURB-65 score of 0 or 1 and absence of hypoxemia. Sputum cultures were ordered for 110 specimens; however, an evaluable sample was obtained in only 49 (45 %) cases. Median time from antibiotic initiation to specimen collection was 11 [interquartile range (IQR) 6-19] h, and a potential pathogen was identified in only 18 (16 %) cultures. Blood cultures were routinely obtained for both non-ICU (81 %) and ICU (95 %) cases, but 15 of 36 (42 %) positive cultures were false-positive results. The most common antibiotic regimen was ceftriaxone + azithromycin (182, 87 % cases). Discordant with IDSA/ATS recommendations, oral step-down therapy consisted of a new antibiotic class in 120 (66 %), most commonly levofloxacin (101, 55 %). Treatment durations were typically longer than suggested with a median of 10 (IQR 8-12) days.

Conclusions: In this cohort of patients hospitalized for CAP, management was frequently inconsistent with IDSA/ATS guideline recommendations, revealing potential targets to reduce unnecessary antibiotic and healthcare resource utilization.

Citing Articles

Attitudes and Practices of the Use of Third-Generation Cephalosporins among Medical Doctors Practicing in Cameroon.

Zeukoo Menkem E, Labo Nanfah A, Takang T, Ryan Awah L, Awah Achua K, Ekane Akume S Int J Clin Pract. 2023; 2023:8074413.

PMID: 36846498 PMC: 9946740. DOI: 10.1155/2023/8074413.

Antibiotic Overuse After Hospital Discharge: A Multi-hospital Cohort Study.

Vaughn V, Gandhi T, Chopra V, Petty L, Giesler D, Malani A Clin Infect Dis. 2020; 73(11):e4499-e4506.

PMID: 32918077 PMC: 7947015. DOI: 10.1093/cid/ciaa1372.

Antibiotic use practice and predictors of hospital outcome among patients with systemic bacterial infection: Identifying targets for antibiotic and health care resource stewardship.

Alemkere G, Tenna A, Engidawork E PLoS One. 2019; 14(2):e0212661.

PMID: 30794660 PMC: 6386277. DOI: 10.1371/journal.pone.0212661.

A Primary Hospital Antimicrobial Stewardship Intervention on Pneumonia Treatment Duration.

Cole J, Stark J, Hodge B Fed Pract. 2019; 34(2):14-18.

PMID: 30766252 PMC: 6372026.

CDS in a Learning Health Care System: Identifying Physicians' Reasons for Rejection of Best-Practice Recommendations in Pneumonia through Computerized Clinical Decision Support.

Jones B, Collingridge D, Vines C, Post H, Holmen J, Allen T Appl Clin Inform. 2019; 10(1):1-9.

PMID: 30602195 PMC: 6327742. DOI: 10.1055/s-0038-1676587.

References

Chen T, Lu P, Lin C, Lin W, Chen Y . Fluoroquinolones are associated with delayed treatment and resistance in tuberculosis: a systematic review and meta-analysis. Int J Infect Dis. 2011; 15(3):e211-6. DOI: 10.1016/j.ijid.2010.11.008. View

Kallen A, Thompson A, Ristaino P, Chapman L, Nicholson A, Sim B . Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect Control Hosp Epidemiol. 2009; 30(3):264-72. DOI: 10.1086/595694. View

Katz D, Leung A . Radiology of pneumonia. Clin Chest Med. 1999; 20(3):549-62. DOI: 10.1016/s0272-5231(05)70235-5. View

. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005; 171(4):388-416. DOI: 10.1164/rccm.200405-644ST. View

Lim W, van der Eerden M, Laing R, Boersma W, Karalus N, Town G . Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003; 58(5):377-82. PMC: 1746657. DOI: 10.1136/thorax.58.5.377. View

Adam H, Hoban D, Gin A, Zhanel G . Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006. Int J Antimicrob Agents. 2009; 34(1):82-5. DOI: 10.1016/j.ijantimicag.2009.02.002. View

Ramirez J, Vargas S, Ritter G, Brier M, Wright A, Smith S . Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med. 2000; 159(20):2449-54. DOI: 10.1001/archinte.159.20.2449. View

Mansouri M, Cadle R, Agbahiwe S, Musher D . Impact of an antibiotic restriction program on antibiotic utilization in the treatment of community-acquired pneumonia in a Veterans Affairs Medical Center. Infection. 2011; 39(1):53-8. PMC: 3071854. DOI: 10.1007/s15010-010-0078-0. View

Garcia-Vazquez E, Marcos M, Mensa J, de Roux A, Puig J, Font C . Assessment of the usefulness of sputum culture for diagnosis of community-acquired pneumonia using the PORT predictive scoring system. Arch Intern Med. 2004; 164(16):1807-11. DOI: 10.1001/archinte.164.16.1807. View

10.

Marrie T, Lau C, Wheeler S, Wong C, Vandervoort M, Feagan B . A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin. JAMA. 2000; 283(6):749-55. DOI: 10.1001/jama.283.6.749. View

11.

Pepin J, Saheb N, Coulombe M, Alary M, Corriveau M, Authier S . Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis. 2005; 41(9):1254-60. DOI: 10.1086/496986. View

12.

Smith-Bindman R, Lipson J, Marcus R, Kim K, Mahesh M, Gould R . Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med. 2009; 169(22):2078-86. PMC: 4635397. DOI: 10.1001/archinternmed.2009.427. View

13.

Bartlett J, Rosenblatt J, Finegold S . Percutaneous transtracheal aspiration in the diagnosis of anaerobic pulmonary infection. Ann Intern Med. 1973; 79(4):535-40. DOI: 10.7326/0003-4819-79-4-535. View

14.

Afshar N, Tabas J, Afshar K, Silbergleit R . Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review. J Hosp Med. 2009; 4(2):112-23. DOI: 10.1002/jhm.382. View

15.

MacDougall C, Powell J, Johnson C, Edmond M, Polk R . Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis. 2005; 41(4):435-40. DOI: 10.1086/432056. View

16.

Hall M, DeFrances C, Williams S, Golosinskiy A, Schwartzman A . National Hospital Discharge Survey: 2007 summary. Natl Health Stat Report. 2010; (29):1-20, 24. View

17.

Pakyz A, MacDougall C, Oinonen M, Polk R . Trends in antibacterial use in US academic health centers: 2002 to 2006. Arch Intern Med. 2008; 168(20):2254-60. DOI: 10.1001/archinte.168.20.2254. View

18.

Gabow P, Eisert S, Wright R . Denver Health: a model for the integration of a public hospital and community health centers. Ann Intern Med. 2003; 138(2):143-9. DOI: 10.7326/0003-4819-138-2-200301210-00016. View

19.

Alahmadi Y, Aldeyab M, McElnay J, Scott M, Darwish Elhajji F, Magee F . Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect. 2011; 77(3):233-6. DOI: 10.1016/j.jhin.2010.09.033. View

20.

Walls R, Resnick J . The Joint Commission on Accreditation of Healthcare Organizations and Center for Medicare and Medicaid Services community-acquired pneumonia initiative: what went wrong?. Ann Emerg Med. 2005; 46(5):409-11. DOI: 10.1016/j.annemergmed.2005.07.018. View